Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM\/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis - Martin_2015_Oncologist_20_111 |
| Author(s) : Martin M , Martinez N , Ramos M , Calvo L , Lluch A , Zamora P , Munoz M , Carrasco E , Caballero R , Garcia-Saenz JA , Guerra E , Caronia D , Casado A , Ruiz-Borrego M , Hernando B , Chacon JI , De la Torre-Montero JC , Jimeno MA , Heras L , Alonso R , De la Haba J , Pita G , Constenla M , Gonzalez-Neira A |
| Ref : Oncologist , 20 :111 , 2015 |
| Abstract : Martin_2015_Oncologist_20_111 |
| ESTHER : Martin_2015_Oncologist_20_111 |
| PubMedSearch : Martin_2015_Oncologist_20_111 |
| PubMedID: 25601966 |
| Title : Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study - Martin_2011_J.Clin.Oncol_29_1008 |
| Author(s) : Martin M , Martinez N , Ramos M , Calvo L , Lluch A , Zamora P , Munoz-Mateu M , Caronia D , Carrasco EM , Garcia Saenz JA , Casado A , Chacon I , Hernando B , Ruiz-Borrego M , Gonzalez-Neira A |
| Ref : J Clin Oncol , 29 :1008 , 2011 |
| Abstract : Martin_2011_J.Clin.Oncol_29_1008 |
| ESTHER : Martin_2011_J.Clin.Oncol_29_1008 |
| PubMedSearch : Martin_2011_J.Clin.Oncol_29_1008 |
| PubMedID: 28020778 |